CAR-T and cellular gene therapies are too expensive

Caring Cross is a 501(c)(3) non-profit focused upon accelerating the development and implementation of advanced medicines like CAR-T cell and stem cell gene therapies. In partnership with like-minded stakeholders, Caring Cross develops and deploys technologies, systems, and therapeutic candidates that improve the affordability and accessibility of these potentially life-saving therapies for all patients in need, everywhere.